J1611 – Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1611
- Long description
- Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg
- Short description
- Inj glucagon hcl, fresenius
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2023
- Last change
- January 1, 2023 – No change
Frequently asked questions
What is HCPCS code J1611?
J1611 is a HCPCS Level II code for injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg.
Does Medicare cover J1611?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1595 – Injection, glatiramer acetate, 20 mg
- J1596 – Injection, glycopyrrolate, 0.1 mg
- J1597 – Injection, glycopyrrolate (glyrx-pf), 0.1 mg
- J1598 – Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg
- J1599 – Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg
- J1600 – Injection, gold sodium thiomalate, up to 50 mg
- J1602 – Injection, golimumab, 1 mg, for intravenous use
- J1610 – Injection, glucagon hydrochloride, per 1 mg
- J1612 – Injection, glucagon (gvoke), 0.01 mg
- J1620 – Injection, gonadorelin hydrochloride, per 100 mcg
- J1626 – Injection, granisetron hydrochloride, 100 mcg
- J1627 – Injection, granisetron, extended-release, 0.1 mg
- J1628 – Injection, guselkumab, 1 mg
- J1630 – Injection, haloperidol, up to 5 mg
- J1631 – Injection, haloperidol decanoate, per 50 mg
- J1632 – Injection, brexanolone, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.